Show Me How Print Item Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash Accounts receivable (net) $230,050 $212,280 83,340 76,240 235,260 225,730 0 87,450 Land 120,670 259,570 199,570o (60,770) (53,820) Equpment Accumulated depredation-equipment Total assets $868,120 $747,450 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) Accrued expenses payable (operating expenses) Dividends payable Common stock, $10 par Paid-in capital: Excess of issue price over par-common stock 157,130 $147,250 15,630 19,430 8,6806,730 46,880 36,630 176,230 101,650 463,570 435,760 $868,120 $747,450 Retained earnings Total liabilities and stockholders' equity Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows 5 more Check My Work uses remaining MacBook Air 4) FS F8 F9 F1O F11 F12